Verrica Pharmaceuticals宣布5000万美元PIPE融资

2025-11-24 21:40

Verrica Pharmaceuticals (VRCA) said it has signed securities purchase agreements for a private investment in public equity (PIPE) that will raise about $50 million in gross proceeds before fees.
The financing is expected to close around November 25, 2025, pending standard closing conditions.
Under the securities purchase agreements, Verrica will sell 6,499,826 common shares and/or pre-funded warrants for 5,305,164 shares, along with Series C warrants to buy 2,951,241 shares, at a combined price of $4.24125 per share of common stock and accompanying Series C warrant.
Verrica (VRCA) plans to use $35 million from the PIPE’s initial closing to fully repay and terminate its credit agreement with OrbiMed. The remaining funds will go toward working capital and general corporate needs. With the PIPE proceeds and its current cash, the company expects to be funded through mid-2027.
VRCA +3.5% premarket to $4.3603
Source: Press Release

More on Verrica Pharmaceuticals